Viewing nowTopstatin 20mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
DaeHwa Pharmaceutical Co., Ltd.

MFDS item code 201000979 · Approved 2010.01.28 · Insurance code 645603800
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is primarily used as an adjunct therapy in patients with primary hypercholesterolemia and mixed dyslipidemia whose conditions are not controlled by diet and exercise alone. It may also be used as an adjunct to other therapies in patients with homozygous familial hypercholesterolemia. Additionally, it helps lower total cholesterol and LDL cholesterol levels, delaying the progression of atherosclerosis and assisting in cholesterol control in high-risk pediatric patients. It is also used as an adjunct to diet in patients with primary dysbetalipoproteinemia and contributes to reducing the risk of cardiovascular diseases. Ultimately, it is effective for improving blood lipid levels and lowering the risk of cardiovascular complications.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, the treatment goal, and the patient's response, and may be increased up to a maximum of 20 mg daily. 3. Elderly patients : No dose adjustment is necessary. 4. Patients with renal impairment : No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but exposure was increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : Since systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (aged 10 to 17 years): The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) Children younger than 10 years: Safety and efficacy have not been established.
This medication should not be administered to certain patients. For instance, individuals with allergies to any of its components, patients with severe liver dysfunction, those with muscle disorders, patients with severe kidney impairment, and women who are pregnant or breastfeeding should not use this medication. This medication can affect liver health, therefore, patients with a history of liver disease or those who consume alcohol excessively should undergo regular liver function tests before and during treatment. If there are conditions such as hypothyroidism, treatment for that condition should be completed before starting this medication. Muscle-related adverse reactions may occur, so if symptoms such as muscle pain or weakness develop, they should immediately inform healthcare professionals. Particularly, if muscle enzyme levels are elevated, discontinuation of this medication may be required. This medication may raise blood sugar levels in some patients, so those at high risk for diabetes should consistently monitor their blood sugar. Interactions may occur when taken with other medications, therefore, patients taking other drugs should inform their healthcare provider and consult them. This is particularly important when taken with certain antiviral agents, immunosuppressants, antibiotics, or fibrate medications. Women who may become pregnant should use appropriate contraception while taking this medication and should not use it during pregnancy. Breastfeeding women should also avoid using this medication. In case of overdose, there is no specific antidote; therefore, treatment should be symptomatic, and liver and muscle function tests may be necessary. Patients may experience dizziness or headaches when taking this medication, so caution should be observed while driving or operating machinery. Finally, if skin rash or severe allergic reactions occur while taking this medication, they should immediately stop taking the drug and contact healthcare professionals.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenic syndrome, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruptions, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is best kept at a temperature between 1 to 30 degrees Celsius at room temperature. Proper storage will help maintain the effect of the medicine for a longer period.
Pink round film-coated tablet
Blister - 28 tablets/box [(14 tablets/blister) X 2], Bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
DaeHwa Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.